Xcout IntelSign inSubscribe

DrFirst

Healthcare TechnologyUnited States

RxInform is a secure messaging platform developed by DrFirst that helps healthcare providers connect patients with prescription information, education, and savings.

Subscribe to see DrFirst’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

DrFirst at a glance

DrFirst is a healthcare technology company headquartered in United States. It has raised at least $50M across the 2 funding rounds on record, 1 of them with a disclosed amount. Its most recent funding round, Growth, raised $50M in May 2021.

Industry
Healthcare Technology
Headquarters
United States
Raised, rounds on record
$50M

DrFirst funding rounds

At least $50M raised across the 2 rounds on record (1 with a disclosed amount). Every round on record:

DateRoundAmountInvestors
Growth$50M1 named
DebtUndisclosed—

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Investors

DrFirst competitors

A few of DrFirst's closest competitors — see the full list of competitors and alternatives →

Get DrFirst's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

DrFirst — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on DrFirst in Xcout Intel

  • 2 funding rounds with the investors in each, and who they co-invest with
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →